Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 38% ± 12% | |
ciliated cell | 3 studies | 25% ± 5% | |
GABAergic neuron | 3 studies | 33% ± 6% | |
glutamatergic neuron | 3 studies | 43% ± 10% | |
oligodendrocyte precursor cell | 3 studies | 18% ± 2% | |
enteroendocrine cell | 3 studies | 28% ± 7% | |
intestinal crypt stem cell | 3 studies | 22% ± 3% | |
club cell | 3 studies | 18% ± 1% | |
basal cell | 3 studies | 32% ± 8% | |
transit amplifying cell | 3 studies | 27% ± 10% | |
goblet cell | 3 studies | 21% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 32% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 1435.10 | 328 / 328 | 98% | 7.92 | 174 / 178 |
thymus | 100% | 1499.70 | 650 / 653 | 94% | 8.76 | 567 / 605 |
ovary | 95% | 880.81 | 171 / 180 | 97% | 10.00 | 415 / 430 |
prostate | 98% | 1594.17 | 241 / 245 | 91% | 9.97 | 457 / 502 |
stomach | 76% | 946.29 | 274 / 359 | 91% | 7.64 | 259 / 286 |
adrenal gland | 81% | 328.00 | 210 / 258 | 80% | 7.53 | 183 / 230 |
kidney | 100% | 1305.19 | 89 / 89 | 61% | 3.52 | 548 / 901 |
uterus | 69% | 397.49 | 117 / 170 | 87% | 8.29 | 401 / 459 |
breast | 60% | 715.50 | 277 / 459 | 90% | 9.94 | 1008 / 1118 |
lung | 71% | 343.40 | 410 / 578 | 76% | 5.88 | 876 / 1155 |
intestine | 48% | 340.34 | 459 / 966 | 92% | 8.66 | 485 / 527 |
bladder | 43% | 382.62 | 9 / 21 | 92% | 8.62 | 462 / 504 |
esophagus | 40% | 468.57 | 575 / 1445 | 86% | 8.43 | 157 / 183 |
brain | 94% | 805.58 | 2474 / 2642 | 22% | 0.69 | 152 / 705 |
skin | 88% | 1556.75 | 1591 / 1809 | 13% | 0.60 | 59 / 472 |
liver | 27% | 78.92 | 62 / 226 | 40% | 2.24 | 162 / 406 |
tonsil | 0% | 0 | 0 / 0 | 62% | 4.57 | 28 / 45 |
eye | 0% | 0 | 0 / 0 | 39% | 2.71 | 31 / 80 |
blood vessel | 28% | 94.46 | 380 / 1335 | 0% | 0 | 0 / 0 |
adipose | 7% | 22.05 | 81 / 1204 | 0% | 0 | 0 / 0 |
muscle | 4% | 11.05 | 33 / 803 | 0% | 0 | 0 / 0 |
heart | 4% | 9.47 | 32 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.29 | 1 / 29 |
peripheral blood | 3% | 7.57 | 27 / 929 | 0% | 0 | 0 / 0 |
spleen | 2% | 6.82 | 6 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0098869 | Biological process | cellular oxidant detoxification |
GO_0019852 | Biological process | L-ascorbic acid metabolic process |
GO_0071243 | Biological process | cellular response to arsenic-containing substance |
GO_0006749 | Biological process | glutathione metabolic process |
GO_0005737 | Cellular component | cytoplasm |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0045174 | Molecular function | glutathione dehydrogenase (ascorbate) activity |
GO_0050610 | Molecular function | methylarsonate reductase activity |
GO_0016491 | Molecular function | oxidoreductase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0004364 | Molecular function | glutathione transferase activity |
Gene name | GSTO2 |
Protein name | Glutathione S-transferase omega-2 (GSTO-2) (EC 2.5.1.18) (Glutathione S-transferase omega 2-2) (GSTO 2-2) (Glutathione-dependent dehydroascorbate reductase) (EC 1.8.5.1) (Monomethylarsonic acid reductase) (MMA(V) reductase) (EC 1.20.4.2) |
Synonyms | |
Description | FUNCTION: Exhibits glutathione-dependent thiol transferase activity. Has high dehydroascorbate reductase activity and may contribute to the recycling of ascorbic acid. Participates in the biotransformation of inorganic arsenic and reduces monomethylarsonic acid (MMA). . |
Accessions | ENST00000450629.6 [Q9H4Y5-2] Q9H4Y5 ENST00000338595.7 [Q9H4Y5-1] ENST00000369707.2 [Q9H4Y5-3] |